Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Heart patients treated by non-cardiologists less likely to receive medications

14.01.2005


Patients with congestive heart failure (CHF) are less likely to be discharged from the hospital with a prescription for an ACE inhibitor and other recommended medications if they are treated by a non-cardiologist, according to a study written by pharmacists at Northwestern Memorial Hospital and published January 15 in the American Journal of Health-System Pharmacy. Beta-blockers, ACE inhibitors, and aldosterone antagonists have been shown to significantly decrease morbidity and mortality and are among the medications recommended by the Heart Failure Society of America (HFSA) to treat CHF, which affects nearly 5 million Americans.



Prescribing differences were demonstrated for several key medications, including:

  • ACE inhibitor (prescribed for 61 percent of patients upon discharge by cardiologists versus 35 percent by non-cardiologists)
  • Beta-blocker (prescribed for 65 percent of patients upon discharge by a cardiologist versus 32 percent by non-cardiologists)
  • Aldosterone antagonist (prescribed for 17 percent of patients upon discharge by a cardiologist versus 7 percent by non-cardiologists)

The study also found that cardiologists are more likely to admit a CHF patient to the Intensive Care Unit and order diagnostic tests, including chest x-rays, electrocardiograms, nuclear medicine tests, cardiac catheterizations, and stress tests, without significantly increasing a patient’s length of stay.

Study authors urge patients to take an active role in their treatment and ask about available medications. "Furthermore, patients or their family members should ask to speak to the hospital pharmacist whenever they have questions about their medicine," explains Jean A. Patel, Pharm. D., clinical pharmacist at Northwestern Memorial Hospital and lead author of the study.


The study was co-authored by Michael A. Fotis, B.S. Pharm, manager of drug information service at Northwestern Memorial Hospital.

Patty Keiler | EurekAlert!
Further information:
http://www.nmh.org
http://www.ashp.org
http://www.SafeMedication.com

More articles from Studies and Analyses:

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>